Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
13.1M
-
Shares change
-
-634K
-
Total reported value, excl. options
-
$45.5M
-
Value change
-
-$2.39M
-
Number of buys
-
20
-
Number of sells
-
-21
-
Price
-
$3.47
Significant Holders of Boundless Bio, Inc. - Common Stock, par value $0.0001 per share (BOLD) as of Q3 2024
58 filings reported holding BOLD - Boundless Bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Boundless Bio, Inc. - Common Stock, par value $0.0001 per share (BOLD) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.1M shares
.
Largest 10 shareholders include FMR LLC (3.34M shares), RA CAPITAL MANAGEMENT, L.P. (2.18M shares), Nextech Invest Ltd. (1.23M shares), Redmile Group, LLC (1.02M shares), WELLINGTON MANAGEMENT GROUP LLP (948K shares), CITADEL ADVISORS LLC (719K shares), Boxer Capital, LLC (711K shares), SECTORAL ASSET MANAGEMENT INC (679K shares), BlackRock, Inc. (409K shares), and Alyeska Investment Group, L.P. (300K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.